Embla Medical hf.
OSSFF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,728 | $1,702 | $1,516 | $2,736 |
| - Cash | $86 | $73 | $77 | $85 |
| + Debt | $500 | $468 | $481 | $448 |
| Enterprise Value | $2,142 | $2,097 | $1,921 | $3,099 |
| Revenue | $855 | $786 | $719 | $719 |
| % Growth | 8.8% | 9.3% | -0% | – |
| Gross Profit | $500 | $454 | $408 | $421 |
| % Margin | 58.5% | 57.8% | 56.8% | 58.6% |
| EBITDA | $168 | $143 | $118 | $151 |
| % Margin | 19.6% | 18.2% | 16.4% | 20.9% |
| Net Income | $68 | $58 | $43 | $64 |
| % Margin | 8% | 7.4% | 5.9% | 8.9% |
| EPS Diluted | 0.16 | 0.14 | 0.1 | 0.15 |
| % Growth | 14.3% | 40% | -33.3% | – |
| Operating Cash Flow | $116 | $94 | $61 | $101 |
| Capital Expenditures | -$39 | -$42 | -$26 | -$27 |
| Free Cash Flow | $77 | $52 | $35 | $74 |